Asia-Pacific Multiplex Assay Market 2021-2028

This research report on the Asia-Pacific multiplex assay market infers that the market is expected to gain a CAGR of 9.64% during the assessed years 2021-2028. Australia & New Zealand, ASEAN countries, China, South Korea, Japan, India, and Rest of APAC outline the region’s overall market.

In India, the increase in tobacco consumption, along with smoking, has increased cancer cases. In this regard, it is estimated by the International Agency for Research on Cancer that the cancer cases are likely to proliferate by 2030. This growth has led to the launch of India Against Cancer initiative by the National Institute of Cancer Prevention and Research to offer information on cancer-related treatments. Furthermore, the Indian Cancer Society has introduced a cancer awareness campaign to increase awareness about screening for early detection and treatment. This rise in cancer cases is likely to enhance the demand for the multiplex assay market across the country.

Likewise, cancer cases have surged significantly in South Korea. This has supported the stable growth of the studied market, owing to the rising demand for quality healthcare. Besides, the increasing demand for molecular testing and point-of-care testing further contributes to the market’s progress. Further, the government has taken initiatives to promote medical tourism, implementing u-healthcare, and regulating multiplex assay. Other than this, the growing acceptance of multiplex assay tests has stimulated the development of new tests, augmenting the development of the South Korean multiplex assay market.

COMPETITIVE OUTLOOK

The well-known companies in the multiplex assay market include Qiagen NV, Thermo Fisher Scientific Inc, Abcam, Siemens Healthineers AG, Bio Rad Laboratories Inc, Seegene Inc, Bio Techne corporation, and Olink Proteomics AB.

1. Asia-Pacific Multiplex Assay Market - Summary

2. Industry Outlook

2.1. Impact of COVID-19 on Multiplex Assay Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Key Buying Outlook
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Market Strategies
2.7.1. Contracts and Partnerships
2.7.2. Business Expansions, Announcements, & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. New Product Launches & Developments
2.8. Key Drivers
2.8.1. Adoption of Personalized Medicines
2.8.2. High Adoption of Multiplex Assays Over Traditional Methods
2.9. Key Restraints
2.9.1. Dearth of Skilled Professionals
2.9.2. Legal Trends Related to Environmental Safety
2.10. Key Opportunities
2.10.1. Funding for R&D Activities by Various Government Agencies and Companies
2.10.2. Emerging Economies Offering Lucrative Growth Opportunities

3. Asia-Pacific Multiplex Assay Market - by Product and Service

3.1. Reagents and Consumables
3.2. Instruments and Accessories
3.3. Software and Services

4. Asia-Pacific Multiplex Assay Market - by Type

4.1. Protein-Based Multiplex Assay
4.2. Nucleic Acid-Based Multiplex Assay
4.3. Other Multiplex Assays

5. Asia-Pacific Multiplex Assay Market - by Application

5.1. Research and Development
5.2. Clinical Diagnostics
5.3. Companion Diagnostics

6. Asia-Pacific Multiplex Assay Market - by Technology

6.1. Multiplex Protein Microarray
6.2. Multiplex Pcr
6.3. Other Technologies

7. Asia-Pacific Multiplex Assay Market - by Industry Verticals

7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
7.3. Clinical Laboratories
7.4. Hospitals

8. Asia-Pacific Multiplex Assay Market - Country Outlook

8.1. Country Analysis
8.1.1. China
8.1.2. Japan
8.1.3. India
8.1.4. Australia & New Zealand
8.1.5. South Korea
8.1.6. Asean Countries
8.1.7. Rest of Asia-Pacific

9. Competitive Landscape

9.1. Abcam
9.2. Agilent Technologies Inc
9.3. Becton Dickinson and Company
9.4. Bio Rad Laboratories Inc
9.5. Bio Techne Corporation
9.6. F Hoffmann La Roche
9.7. Illumina Inc
9.8. Luminex Corporation
9.9. Merck Millipore
9.10. Meso Scale Diagnostics LLC
9.11. Olink Proteomics Ab
9.12. Qiagen Nv
9.13. Randox Laboratories Ltd
9.14. Seegene Inc
9.15. Siemens Healthineers AG
9.16. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

10.1. Research Scope & Deliverables
10.1.1. Objectives of Study
10.1.2. Scope of Study
10.2. Sources of Data
10.2.1. Primary Data Sources
10.2.2. Secondary Data Sources
10.3. Research Methodology
10.3.1. Evaluation of Proposed Market
10.3.2. Identification of Data Sources
10.3.3. Assessment of Market Determinants
10.3.4. Data Collection
10.3.5. Data Validation & Analysis

List of Tables

Table 1: Asia-Pacific Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Contracts and Partnerships
Table 4: List of Business Expansions, Announcements, & Divestitures
Table 5: Acquisitions & Mergers
Table 6: List of New Product Launches & Developments
Table 7: Asia-Pacific Multiplex Assay Market, by Product and Service, 2021-2028 (In $ Million)
Table 8: Asia-Pacific Multiplex Assay Market, by Type, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Multiplex Assay Market, by Application, 2021-2028 (In $ Million)
Table 10: Asia-Pacific Multiplex Assay Market, by Technology, 2021-2028 (In $ Million)
Table 11: Asia-Pacific Multiplex Assay Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 12: Asia-Pacific Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)

List of Figures

Figure 1: Asia-Pacific Multiplex Assay Market 2021-2028 (In $ Million)
Figure 2: Asia-Pacific Multiplex Assay Market, by Product and Service, 2020 & 2028 (In %)
Figure 3: Asia-Pacific Multiplex Assay Market, by Reagents and Consumables, 2021-2028 (In $ Million)
Figure 4: Asia-Pacific Multiplex Assay Market, by Instruments and Accessories, 2021-2028 (In $ Million)
Figure 5: Asia-Pacific Multiplex Assay Market, by Software and Services, 2021-2028 (In $ Million)
Figure 6: Asia-Pacific Multiplex Assay Market, by Type, 2020 & 2028 (In %)
Figure 7: Asia-Pacific Multiplex Assay Market, by Protein-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Multiplex Assay Market, by Nucleic Acid-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Multiplex Assay Market, by Other Multiplex Assays, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Multiplex Assay Market, by Application, 2020 & 2028 (In %)
Figure 11: Asia-Pacific Multiplex Assay Market, by Research and Development, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Multiplex Assay Market, by Clinical Diagnostics, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Multiplex Assay Market, by Companion Diagnostics, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Multiplex Assay Market, by Technology, 2020 & 2028 (In %)
Figure 15: Asia-Pacific Multiplex Assay Market, by Multiplex Protein Microarray, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Multiplex Assay Market, by Multiplex Pcr, 2021-2028 (In $ Million)
Figure 17: Advantages of Immunohistochemistry (Ihc)
Figure 18: Asia-Pacific Multiplex Assay Market, by Other Technologies, 2021-2028 (In $ Million)
Figure 19: Asia-Pacific Multiplex Assay Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 20: Asia-Pacific Multiplex Assay Market, by Pharmaceutical & Biotechnology Companies, 2021-2028 (In $ Million)
Figure 21: Asia-Pacific Multiplex Assay Market, by Research Institutes, 2021-2028 (In $ Million)
Figure 22: Asia-Pacific Multiplex Assay Market, by Clinical Laboratories, 2021-2028 (In $ Million)
Figure 23: Asia-Pacific Multiplex Assay Market, by Hospitals, 2021-2028 (In $ Million)
Figure 24: China Multiplex Assay Market 2021-2028 (In $ Million)
Figure 25: Japan Multiplex Assay Market 2021-2028 (In $ Million)
Figure 26: India Multiplex Assay Market 2021-2028 (In $ Million)
Figure 27: Australia & New Zealand Multiplex Assay Market 2021-2028 (In $ Million)
Figure 28: South Korea Multiplex Assay Market 2021-2028 (In $ Million)
Figure 29: Asean Countries Multiplex Assay Market 2021-2028 (In $ Million)
Figure 30: Rest of Asia-Pacific Multiplex Assay Market 2021-2028 (In $ Million)